Center of Otorhinolaryngology of People's Liberation Army, Navy General Hospital, Beijing 100037, China.
Chin Med J (Engl). 2010 Feb 5;123(3):291-5.
Surgical treatments for chronic suppurative and cholesteatoma otitis media have been discussed for several decades, but recurrences still occur because of the complex dissection required and hidden lesions associated with otomastoiditis. This study investigated the technology and strategy behind the use of otoendoscopic-assisted otosurgery.
We reported on hidden lesions in 32 ears of patients with otomastoiditis between November 2006 and January 2009. All the patients were treated with the aid of an otoendoscope. The advantages of otoendoscopy, including multi-angle light scattering, aperture illumination, and magnification of the local operative field, were utilized in otologic microsurgery, and otoendoscopic operative techniques were introduced for operative sites such as the epitympanum, aditus of the antrum, facial recess, sinus tympani and the mastoid tip.
All patients were followed up from 3 months to 2 years after surgery. All patients recovered well within 3 months following surgery, except for one case of epithelialization of the mastoid cavity occurring 6 months after surgery for cholesteatoma on the cerebellar surface and another case with Bezold's abscess, hyperplastic granulation tissue developed at the antrum.
Otoendoscopy can overcome the technical deficiency of rectilinearity of the visual axis associated with otomicroscopic illumination, which presents a problem when dealing with otomastoiditis lesions in hidden areas. This technique allows such lesions within the complex three-dimensional structure to be visualized and cleaned. Otoendoscopy thus has significant potential for improving the quality of surgery and reducing the risk of postoperative recurrence.
慢性化脓性和胆脂瘤性中耳炎的手术治疗已经讨论了几十年,但由于乳突炎相关的复杂解剖和隐匿性病变,仍然会复发。本研究探讨了耳内镜辅助耳科手术背后的技术和策略。
我们报告了 2006 年 11 月至 2009 年 1 月期间 32 例乳突炎患者的隐匿性病变。所有患者均在耳内镜辅助下进行治疗。耳内镜具有多角度光散射、孔径照明和局部手术视野放大等优点,在耳科显微手术中得到了应用,并引入了耳内镜手术技术,用于处理上鼓室、鼓窦入口、面神经隐窝、鼓窦和乳突尖等手术部位。
所有患者术后随访 3 个月至 2 年。除 1 例小脑表面胆脂瘤术后 6 个月乳突腔上皮化和 1 例 BezoId 脓肿、窦腔肉芽组织增生外,所有患者术后 3 个月内均恢复良好。
耳内镜可以克服耳显微镜照明下视轴直线性的技术缺陷,这在处理隐匿性乳突炎病变时是一个问题。该技术可以使复杂的三维结构内的这些病变可视化并进行清理。因此,耳内镜在提高手术质量和降低术后复发风险方面具有重要潜力。